Mylan Expands EpiPen Recall To The U.S.

This article was originally published here
  • Medtech: Here are the best and worst performers of Q1 2017

    More than four-fifths of the 100 largest medical device companies in the world saw their stock prices increase during the first three months of 2017, according to a Medical Design & Outsourcing analysis of how the stocks of our Big 100 companies are faring. The situation suggests that even with the uncertainty around what the […]

  • New Raumedic CEO appointed in the U.S.

    Germany-based Raumedic AG announced that it has appointed William F. Gearhart as CEO at its U.S. operations. He will be responsible for developing the Raumedic brand in North America. “After a thorough search, we concluded that Bill’s leadership and experience in the medical engineering industry, along with his considerable track record of success in the […]

  • RJG now offers Mold Design course

    RJG, Inc. held their first Mold Design class in March of this year. The goal of offering this course is to provide mold makers, design engineers and molders with the common language and core knowledge required to design injection molds that exceed time, cost and quality requirements. Mold Design is meant to bridge the gap […]

  • Saudi Food and Drug Authority plans changes for medical device marketing application

    By Stewart Eisenhart, Emergo Group Saudi Arabia’s medical device regulator, the Saudi Food and Drug Authority (SFDA), plans to introduce changes to the application process for obtaining market authorization in the country. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do […]

  • Gurnet Point buys Innocoll holdings for $209m

    Healthcare investment fund Gurnet Point said today it will acquire Innocoll Holdings for approximately $209 million. Gurnet will put up $1.75 per share in cash and up to $4.90 in cash from a contingent value right, for a potential share value up to $6.65, the company said. During the offer period, Gurnet said it plans to […]

  • DSM introduces the first black medical-grade UHMWPE fiber

    DSM Biomedical has released its Dyneema Purity Black fiber that is the first and only black ultra-high molecular weight polyethylene (UHMWPE) medical fiber. The black fiber builds upon what Dyneema Purity fibers are known for like strength, being that it is 15 times stronger than steel. It also has a small profile, high pliability and […]

  • Fluid Metering has new valveless waste transfer pump

    Fluid Metering is touting a new valveless waste transfer pump that is designed to remove waste fluid created by medical diagnostic instrumentation while analyzing patient fluid samples. Waste fluid usually has a mixture of patient samples, like blood components and urine samples, that get combined with reagents, byproducts of reagent reactions and wash fluids. The […]

  • Masimo touts adult EEG sensor

    Masimo has announced that its RD SedLine EEG sensor is now available in the U.S. The EEG sensor is meant to be used with Masimo SedLine Brain Function Monitoring and is compatible with the O3 Regional Oximetry offered by Masimo. The SedLine and O3 monitor onto the Masimo Root monitoring platform to help clinicians obtain […]

  • The myths of agile project management debunked

    Justin Kelleher, Project Management Consultant, Cora Systems George Orwell once said: “Myths which are believed in tend to become true.” Of course, a story can become a myth or indeed the myth often becomes a good story. This particular story has its genesis in the mountains of Utah, in February 2001, when a gathering of […]

  • Singapore changes medical device field safety notice requirements

    By Stewart Eisenhart, Emergo Group Singapore’s medical device market regulator now requires registrants issuing field safety notices (FSNs) regarding their products to copy managers of affected local healthcare facilities. Get the full story here at the Emergo Group’s blog. The opinions expressed in this blog post are the author’s only and do not necessarily reflect […]

  • How the CellMist SkinGun heals: a Q&A with RenovaCare’s CEO

    When Thomas Bold joined RenovaCare in 2013, he was already familiar with its potentially groundbreaking technology. Bold had served as StemCell Systems CEO in Berlin for many years. He was involved in the development of the CellMist and SkinGun – the platform technologies for RenovaCare Inc. The technologies represent a shift in thinking about wound care, Bold said. Bold’s goal […]

  • 0 replies

    Leave a Reply

    Want to join the discussion?
    Feel free to contribute!

    Leave a Reply